Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.

PLoS One · 2021 · PMC8158910 · PMID 34043677

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

Mean medical costs also increased by about $2000, but this difference did not achieve significance.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.